Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased circulation of echovirus 11 in the general population and hospital patients as elicited by the non-polio enterovirus laboratory-based sentinel surveillance in northern Italy, 2023.
Pellegrinelli L, Galli C, Giardina F, Ferrari G, Uceda Renteria SC, Ceriotti F, Seiti A, Binda S, Pitrolo AMG, Schiavo R, Malandrin SMI, Cavallero A, Arosio M, Farina C, Oggioni M, Congedo P, Cereda D, Rovida F, Piralla A, Pariani E, Baldanti F; Non-polio community-based surveillance group; Non-polio hospital-based surveillance group. Pellegrinelli L, et al. Among authors: malandrin smi. Int J Infect Dis. 2024 May;142:106998. doi: 10.1016/j.ijid.2024.106998. Epub 2024 Mar 7. Int J Infect Dis. 2024. PMID: 38458420 Free article.
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022.
Piralla A, Mojoli F, Pellegrinelli L, Ceriotti F, Valzano A, Grasselli G, Gismondo MR, Micheli V, Castelli A, Farina C, Arosio M, Lorini FL, Fanti D, Busni A, Laratta M, Maggi F, Novazzi F, Cabrini L, Callegaro AP, Keim R, Remuzzi G, Cavallero A, Malandrin SMI, Rona R, Giardina F, Ferrari G, Zavaglio F, D'angelo P, Galli C, Bubba L, Binda S, Oggioni M, Uceda Renteria SC, Bono P, Baj A, Ferrante FD, Guarneri D, Tonelli M, Napolitano G, Nava A, Romeo L, Nicolini E, Valaperta R, Varisano L, Mele C, Liguori L, Raggi M, Mongodi S, Pagani M, Severgnini P, Gasberti D, Bonanomi E, Gritti P, Marrazzo F, Giovannini I, Sacchi N, Sagliocco O, Cereda D, Buoro S, Baldanti F, Pariani E. Piralla A, et al. Among authors: malandrin smi. Respir Med Res. 2023 Jun;83:100990. doi: 10.1016/j.resmer.2023.100990. Epub 2023 Mar 4. Respir Med Res. 2023. PMID: 36871459 Free PMC article.
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study.
Gagliardini R, Ciccullo A, Borghetti A, Maggiolo F, Bartolozzi D, Borghi V, Pecorari M, Di Biagio A, Callegaro AP, Bruzzone B, Saladini F, Paolucci S, Maserati R, Zazzi M, Di Giambenedetto S, De Luca A; ARCA Study Group. Gagliardini R, et al. Open Forum Infect Dis. 2018 May 15;5(6):ofy113. doi: 10.1093/ofid/ofy113. eCollection 2018 Jun. Open Forum Infect Dis. 2018. PMID: 29977967 Free PMC article.
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706).
Bossi E, Aroldi A, Borin LM, Verga L, Fontana D, Cocito F, Manghisi B, Rindone G, Cavalca F, Ripamonti A, Raggi M, Malandrin SMI, Cavallero A, Antolini L, Bonardi D, Piazza RG, Gambacorti-Passerini C. Bossi E, et al. Among authors: malandrin smi. EJHaem. 2022 Aug 30;3(4):1201-8. doi: 10.1002/jha2.544. Online ahead of print. EJHaem. 2022. PMID: 36248617 Free PMC article.
The analysis of saliva as screening in patients with COVID-like symptoms.
Novelli G, Moretti M, Meazzini MC, Bernasconi DP, Malandrin SMI, Raggi M, Cassé CMA, Pavesi LA, Sozzi D. Novelli G, et al. Among authors: malandrin smi. Germs. 2023 Dec 31;13(4):388-391. doi: 10.18683/germs.2023.1410. eCollection 2023 Dec. Germs. 2023. PMID: 38361544 Free PMC article. No abstract available.
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
Di Biagio A, Prinapori R, Giannarelli D, Maggiolo F, Di Giambenedetto S, Borghi V, Penco G, Cicconi P, Francisci D, Sterrantino G, Zoncada A, Monno L, Capetti A, Giacometti A; ARCA Collaborative Group. Di Biagio A, et al. J Antimicrob Chemother. 2013 Jan;68(1):200-5. doi: 10.1093/jac/dks339. Epub 2012 Aug 21. J Antimicrob Chemother. 2013. PMID: 22915463
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study.
Pepe FF, Cazzaniga ME, Baroni S, Riva F, Cicchiello F, Capici S, Cogliati V, Maggioni C, Cordani N, Cerrito MG, Malandrin S. Pepe FF, et al. BMC Cancer. 2022 Sep 6;22(1):956. doi: 10.1186/s12885-022-10031-6. BMC Cancer. 2022. PMID: 36068484 Free PMC article. Clinical Trial.